EMAIL THIS PAGE TO A FRIEND

PloS one

Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.


PMID 26355684

Abstract

Hepatic ischemia and reperfusion injury (IRI) is an inflammatory condition and a significant cause of morbidity and mortality after surgery. Matrix metalloproteinases (MMPs) have been widely implicated in the pathogenesis of inflammatory diseases. Among the different MMPs, gelatinases (MMP-2 and MMP-9) are within the most prominent MMPs detected during liver IRI. While the role of MMP-9 in liver damage has been fairly documented, direct evidence of the role for MMP-2 activity in hepatic IRI remains to be established. Due to the lack of suitable inhibitors to target individual MMPs in vivo, gene manipulation is as an essential tool to assess MMP direct contribution to liver injury. Hence, we used MMP-2-/- deficient mice and MMP-2+/+ wild-type littermates to examine the function of MMP-2 activity in hepatic IRI. MMP-2 expression was detected along the sinusoids of wild-type livers before and after surgery and in a small population of leukocytes post-IRI. Compared to MMP-2+/+ mice, MMP-2 null (MMP-2-/-) mice showed exacerbated liver damage at 6, 24, and 48 hours post-reperfusion, which was fatal in some cases. MMP-2 deficiency resulted in upregulation of MMP-9 activity, spontaneous leukocyte infiltration in naïve livers, and amplified MMP-9-dependent transmigration of leukocytes in vitro and after hepatic IRI. Moreover, complete loss of MMP-2 activity impaired the degradation of poly (ADP-ribose) polymerase (PARP-1) in extensively damaged livers post-reperfusion. However, the administration of a PARP-1 inhibitor to MMP-2 null mice restored liver preservation to almost comparable levels of MMP-2+/+ mice post-IRI. Deficient PARP-1 degradation in MMP-2-null sinusoidal endothelial cells correlated with their increased cytotoxicity, evaluated by the measurement of LDH efflux in the medium. In conclusion, our results show for the first time that MMP-2 gene deletion exacerbates liver IRI. Moreover, they offer new insights into the MMP-2 modulation of inflammatory responses, which could be relevant for the design of new pharmacological MMP-targeted agents to treat hepatic IRI.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AB19167
Anti-MMP-2 Antibody, whole molecule, 100 µg, Detect MMP-2 using this Anti-MMP-2 Antibody, whole molecule validated for use in IH(P) & WB.
SAB4500487
Anti-PARP (Cleaved-Asp214) antibody produced in rabbit, affinity isolated antibody
SAB4500488
Anti-PARP (Cleaved-Gly215) antibody produced in rabbit, affinity isolated antibody
P7605 Anti-PARP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
AV33754
Anti-PARP1 antibody produced in rabbit, IgG fraction of antiserum
HPA045168
Anti-PARP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C5670
Calcium chloride, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
CaCl2
429759
Calcium chloride, anhydrous, beads, −10 mesh, ≥99.99% trace metals basis
CaCl2
499609
Calcium chloride, anhydrous, powder, 99.99% trace metals basis
CaCl2
C8106
Calcium chloride, meets USP testing specifications
CaCl2 · 2H2O
449709
Calcium chloride, anhydrous, beads, −10 mesh, ≥99.9% trace metals basis
CaCl2
21115
Calcium chloride solution, BioUltra, for molecular biology, ~1 M in H2O
CaCl2
P248 Monoclonal Anti-PARP antibody produced in mouse, clone C-2-10, ascites fluid
WH0000142M1
Monoclonal Anti-PARP1 antibody produced in mouse, clone 3G4, purified immunoglobulin, buffered aqueous solution
SAB1403527
Monoclonal Anti-PARP1, (N-terminal) antibody produced in mouse, clone 2C7, purified immunoglobulin, buffered aqueous solution
PLA0184
Rabbit anti-PARP1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
S2889
Sodium acetate, anhydrous, for molecular biology, ≥99%
C2H3NaO2
S3272
Sodium acetate, for electrophoresis, ≥99%, crystalline
C2H3NaO2
S5636
Sodium acetate, powder, BioReagent, for electrophoresis, suitable for cell culture, suitable for insect cell culture, ≥99%
C2H3NaO2
S1429
Sodium acetate, meets USP testing specifications, anhydrous
C2H3NaO2
229873
Sodium acetate, 99.995% trace metals basis
C2H3NaO2
S7545
Sodium acetate, BioXtra, ≥99.0%
C2H3NaO2
71183
Sodium acetate, anhydrous, BioUltra, for luminescence, for molecular biology, ≥99.0% (NT)
C2H3NaO2
W302406
Sodium Acetate Anhydrous, >99%, FCC, FG
C2H3NaO2
S8388
Sodium acetate solution, 0.3 M
C2H3NaO2
71196
Sodium acetate solution, BioUltra, for molecular biology, ~3 M in H2O
C2H3NaO2
S8032
Sodium azide, BioXtra
N3Na
438456
Sodium azide, ≥99.99% trace metals basis
N3Na
S2002
Sodium azide, ReagentPlus®, ≥99.5%
N3Na
71289
Sodium azide, BioUltra, ≥99.5% (T)
N3Na